SNORA42 is frequently overexpressed in lung cancer and colorectal cancer, and knockdown of SNORA42 slows the growth of cancer cells, indicating that SNORA42 is a putative oncogene (Mei et al., 2012). Here, SNORA80E is linked to lung cancer.